Cargando…
MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?
SIMPLE SUMMARY: Despite the declaration of the end of the COVID-19 pandemic in May 2023, several important questions regarding its impact on public health remain unanswered. Specifically, the clinical trials for COVID-19 vaccines did not include cancer patients, leaving a knowledge gap about how vac...
Autores principales: | Almeida, Beatriz, Dias, Tânia R., Teixeira, Ana Luísa, Dias, Francisca, Medeiros, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452664/ https://www.ncbi.nlm.nih.gov/pubmed/37627045 http://dx.doi.org/10.3390/cancers15164017 |
Ejemplares similares
-
Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
por: Teixeira, Ana L, et al.
Publicado: (2014) -
MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response
por: Dias, Tânia R., et al.
Publicado: (2022) -
Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management
por: Almeida, Cristina, et al.
Publicado: (2023) -
LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
por: Dias, Francisca, et al.
Publicado: (2021) -
Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior
por: Dias, Francisca, et al.
Publicado: (2018)